前列腺癌生物标志物的进展:一篇评论
Praise Agbetuyi-Tayo1,2, Mary Gbadebo1,2, Oluwakemi A Rotimi1,2
1Department of Biochemistry, Covenant University, Ota, Nigeria.
Technology in cancer research & treatment
|October 23, 2024
概括
准确的前列腺癌 (PCa) 风险分层至关重要. 本审查审查了既有和新兴的生物标志物,包括前列腺健康指数 (PHI) 和尿非编码RNA,以改善PCa管理.
科学领域:
- 瘤学和泌尿病学 在线咨询
- 生物标志物发现发现
- 癌症研究 癌症研究
背景情况:
- 前列腺癌 (PCa) 是男性癌症死亡的主要原因,发病率和死亡率存在显著差异,特别是在非洲裔男性中.
- PCa表现出广泛的临床行为,需要精确的风险分层来进行有效的治疗和临床试验设计.
- 当前的诊断和预后工具需要不断改进,以准确识别侵袭性疾病并指导治疗决策.
研究的目的:
- 为前列腺癌 (PCa) 诊断和预后提供既定和新兴生物标志物的全面审查.
- 评估各种PCa生物标志物在风险分层和疾病管理中的临床实用性.
- 探索包括微生物群和非编码RNA在内的新途径,以提高PCa的理解和检测.
主要方法:
- 对PCa生物标志物的当前文献进行系统审查.
- 在临床实践中集成的已知生物标志物的分析,如前列腺健康指数 (PHI),4Kscore,STHLM3,PCA3,SelectMDx,ExoDx前列腺智商 (EPI) 和MiPS.
- 评估新兴生物标志物,包括尿非编码RNA,DNA甲基化模式和与瘤相关的微生物群.
主要成果:
- 像PHI,4Kscore和EPI这样的已知生物标志物在改善PCa风险分层和临床决策方面发挥了重要作用.
- 新兴的生物标志物,如尿非编码RNA和DNA甲基化,显示出临床前有望提高诊断和预后准确性.
- 瘤相关微生物群在PCa发病和进展中的作用是一个新兴的领域,具有新的治疗策略的潜力.
结论:
- 既定和新兴的多种生物标志物对准确的前列腺癌风险分层和个性化管理至关重要.
- 对新型生物标志物的持续研究,包括分子和微生物因素,对于推进PCa诊断,预后和治疗至关重要.
- 整合先进的生物标志物策略是改善全球前列腺癌相关结果和降低死亡率的关键.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...